HEPION PHARMACEUTICALS, INC. Fair Value Adjustment of Warrants
HEPION PHARMACEUTICALS, INC. (HEPA) reported Fair Value Adjustment of Warrants of $53.14 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was $42.99K.
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $10.15K, a 99.79% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $34.62K.
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$47.27K.
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2025 was $4.09M.
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2024 was -$5.58M, a 523.43% decline from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2023 was $1.32M.
- HEPION PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2022 was $0.00.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 11 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $53.14K 10-Q · filed 2026-08-13 | $87.76K derived: sum of 3 quarters · filed 2026-08-13 | $40.49K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $10.15K 10-Q · filed 2026-05-14 | $44.77K derived: sum of 2 quarters · filed 2026-05-14 | -$2.50K derived: sum of 3 quarters · filed 2026-05-14 | -$700.58K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $34.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$12.65K derived: sum of 2 quarters · filed 2026-03-12 | -$710.73K derived: sum of 3 quarters · filed 2026-08-13 | $4.09M 10-K · filed 2026-03-12 | ||
| 2025-09-30 | -$47.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$745.35K derived: sum of 2 quarters · filed 2026-08-13 | $4.06M 10-Q · filed 2025-11-12 | $2.98M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$698.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.10M 10-Q · filed 2026-08-13 | $3.03M derived: sum of 3 quarters · filed 2026-08-13 | $2.96M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $4.80M 10-Q · filed 2026-05-14 | $3.73M derived: sum of 2 quarters · filed 2026-05-14 | $3.66M derived: sum of 3 quarters · filed 2026-05-14 | $381.87K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.14M derived: sum of 2 quarters · filed 2026-03-12 | -$4.42M derived: sum of 3 quarters · filed 2026-03-12 | -$5.58M 10-K · filed 2026-03-12 | ||
| 2024-09-30 | -$66.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.35M derived: sum of 2 quarters · filed 2025-11-12 | -$4.51M 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | -$3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$4.44M 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | -$1.16M 10-Q · filed 2025-05-19 | |||||
| 2023-12-31 | $1.32M 10-K · filed 2025-04-08 | |||||
| 2023-10-03 | $3.90M 10-Q · filed 2024-08-13 | |||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-21 | |||||
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | |||||
| 2021-12-31 | $10.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $8.14K derived: sum of 2 quarters · filed 2022-04-08 | $6.21K derived: sum of 3 quarters · filed 2022-04-08 | $0.00 10-K · filed 2022-04-08 | ||
| 2021-09-30 | -$2.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$4.70K derived: sum of 2 quarters · filed 2021-11-15 | -$10.91K 10-Q · filed 2021-11-15 | -$30.07K derived: sum of 4 quarters · filed 2022-04-08 | ||
| 2021-06-30 | -$1.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$8.14K 10-Q · filed 2021-08-16 | -$27.30K derived: sum of 3 quarters · filed 2022-04-08 | -$30.87K derived: sum of 4 quarters · filed 2022-04-08 | ||
| 2021-03-31 | -$6.21K 10-Q · filed 2021-05-14 | -$25.37K derived: sum of 2 quarters · filed 2022-04-08 | -$28.94K derived: sum of 3 quarters · filed 2022-04-08 | -$9.84K derived: sum of 4 quarters · filed 2022-04-08 | ||
| 2020-12-31 | -$19.16K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$22.73K derived: sum of 2 quarters · filed 2022-04-08 | -$3.63K derived: sum of 3 quarters · filed 2022-04-08 | $6.05K 10-K · filed 2022-04-08 | ||
| 2020-09-30 | -$3.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $15.53K derived: sum of 2 quarters · filed 2021-11-15 | $25.21K 10-Q · filed 2021-11-15 | $30.42K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $19.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $28.77K 10-Q · filed 2021-08-16 | $33.99K derived: sum of 3 quarters · filed 2021-08-16 | $25.59K derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $9.68K 10-Q · filed 2021-05-14 | $14.89K derived: sum of 2 quarters · filed 2021-05-14 | $6.49K derived: sum of 3 quarters · filed 2021-05-14 | -$193.12K derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | $5.21K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$3.19K derived: sum of 2 quarters · filed 2021-03-31 | -$202.80K derived: sum of 3 quarters · filed 2021-03-31 | -$398.71K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | -$8.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$208.01K derived: sum of 2 quarters · filed 2020-11-16 | -$403.93K 10-Q · filed 2020-11-16 | -$1.35M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | -$199.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$395.53K 10-Q · filed 2020-08-12 | -$1.34M derived: sum of 3 quarters · filed 2020-08-12 | -$5.19M derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | -$195.92K 10-Q · filed 2020-06-29 | -$1.14M derived: sum of 2 quarters · filed 2020-06-29 | -$4.99M derived: sum of 3 quarters · filed 2020-06-29 | -$5.12M derived: sum of 4 quarters · filed 2020-06-29 | ||
| 2018-12-31 | -$941.43K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | -$4.79M derived: sum of 2 quarters · filed 2020-05-14 | -$4.93M derived: sum of 3 quarters · filed 2020-05-14 | -$5.32M 10-K · filed 2020-05-14 | ||
| 2018-09-30 | -$3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$3.99M derived: sum of 2 quarters · filed 2019-11-14 | -$4.38M 10-Q · filed 2019-11-14 | -$5.35M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$135.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$530.45K 10-Q · filed 2019-08-14 | -$1.50M derived: sum of 3 quarters · filed 2019-08-14 | -$1.59M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | -$395.12K 10-Q · filed 2019-05-15 | -$1.36M derived: sum of 2 quarters · filed 2019-05-15 | -$1.46M derived: sum of 3 quarters · filed 2019-05-15 | -$7.64M derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | -$968.87K derived: 10-K 6 month − 10-Q 3 month · filed 2019-03-14 | -$1.06M 10-K · filed 2019-03-14 | -$7.25M derived: sum of 3 quarters · filed 2019-03-14 | -$5.71M derived: sum of 4 quarters · filed 2019-03-14 | ||
| 2017-09-30 | -$93.90K 10-Q · filed 2017-11-14 | -$6.28M derived: sum of 2 quarters · filed 2018-08-14 | -$4.74M 10-Q · filed 2018-11-14 | -$4.35M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-06-30 | -$6.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$4.65M 10-Q · filed 2018-08-14 | -$4.25M derived: sum of 3 quarters · filed 2018-08-14 | -$4.22M 10-K · filed 2019-03-14 | ||
| 2017-03-31 | $1.54M 10-Q · filed 2018-05-15 | $1.93M derived: sum of 2 quarters · filed 2018-05-15 | $1.87M 10-Q · filed 2017-04-12 | $1.28M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $391.17K 10-Q · filed 2017-02-14 | $331.01K 10-Q · filed 2017-02-14 | -$256.99K derived: sum of 3 quarters · filed 2017-11-14 | -$992.22K derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-09-30 | -$60.16K 10-Q · filed 2017-11-14 | -$648.16K derived: sum of 2 quarters · filed 2017-11-14 | -$1.38M derived: sum of 3 quarters · filed 2017-11-14 | -$3.87M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | -$588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$1.32M derived: sum of 2 quarters · filed 2016-09-28 | -$3.81M derived: sum of 3 quarters · filed 2017-02-14 | -$3.81M 10-K · filed 2016-09-28 | ||
| 2016-03-31 | -$735.23K 10-Q · filed 2016-05-13 | -$3.22M derived: sum of 2 quarters · filed 2017-02-14 | -$3.22M 10-Q · filed 2017-04-12 | |||
| 2015-12-31 | -$2.48M 10-Q · filed 2017-02-14 | -$2.48M 10-Q · filed 2017-02-14 | ||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $0.00 derived: sum of 2 quarters · filed 2016-09-28 | $0.00 derived: sum of 3 quarters · filed 2016-09-28 | $387.90K 10-K · filed 2016-09-28 | ||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2016-05-13 | $387.90K 10-Q · filed 2016-05-13 | -$4.86M derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $387.90K 10-Q · filed 2016-02-12 | -$4.86M derived: sum of 3 quarters · filed 2016-02-12 | $3.98M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-09-30 | $387.90K 10-Q · filed 2015-11-12 | -$4.86M derived: sum of 2 quarters · filed 2015-11-12 | $3.98M derived: sum of 3 quarters · filed 2015-11-12 | |||
| 2014-06-30 | -$5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $3.60M derived: sum of 2 quarters · filed 2015-09-25 | $3.60M 10-K · filed 2015-09-25 | |||
| 2014-03-31 | $8.85M 10-Q · filed 2015-05-14 | $8.85M 10-Q · filed 2015-05-14 | $8.85M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |